These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 6548317)
1. Development of a GC-MS method for quantitation of 2,3-dinor-6-keto-PGF1 alpha and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs. Vesterqvist O; Gréen K Prostaglandins; 1984 Jul; 28(1):139-54. PubMed ID: 6548317 [TBL] [Abstract][Full Text] [Related]
2. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry. Chiabrando C; Pinciroli V; Campoleoni A; Benigni A; Piccinelli A; Fanelli R J Chromatogr; 1989 Oct; 495():1-11. PubMed ID: 2613794 [TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects. Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057 [TBL] [Abstract][Full Text] [Related]
4. Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin. Böger RH; Bode-Böger SM; Schröder EP; Tsikas D; Frölich JC J Appl Physiol (1985); 1995 May; 78(5):1832-8. PubMed ID: 7649919 [TBL] [Abstract][Full Text] [Related]
5. Application of an alpha-sidechain length-specific monoclonal antibody to immunoaffinity purification and enzyme immunoassay of 2,3-dinor-6-keto-prostaglandin F1 alpha from human urine. Hiramatsu M; Hayashi Y; Yamamoto S; Hayashi A; Sawada M; Hamanaka N; Yamashita K Prostaglandins Leukot Essent Fatty Acids; 1994 Feb; 50(2):69-79. PubMed ID: 8171070 [TBL] [Abstract][Full Text] [Related]
6. Simplified assay for the quantification of 2,3-dinor-6-keto-prostaglandin F1 alpha by gas chromatography-mass spectrometry. Daniel VC; Minton TA; Brown NJ; Nadeau JH; Morrow JD J Chromatogr B Biomed Appl; 1994 Mar; 653(2):117-22. PubMed ID: 8205238 [TBL] [Abstract][Full Text] [Related]
7. Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin. Balazy M; Brass EP; Gerber JG; Nies AS Prostaglandins; 1988 Oct; 36(4):421-30. PubMed ID: 3070630 [TBL] [Abstract][Full Text] [Related]
8. Determination of 6-keto-PGF1 alpha, 2,3-dinor-6-keto-PGF1 alpha, thromboxane B2, 2,3-dinor-thromboxane B2, PGE2, PGD2 and PGF2 alpha in human urine by gas chromatography-negative ion chemical ionization mass spectrometry. Weber C; Höller M; Beetens J; De Clerck F; Tegtmeier F J Chromatogr; 1991 Jan; 562(1-2):599-611. PubMed ID: 2026723 [TBL] [Abstract][Full Text] [Related]
9. Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Evidence from measurements of the major urinary metabolite of prostacyclin by GC-MS. Vesterqvist O Eur J Clin Pharmacol; 1986; 30(1):69-73. PubMed ID: 3519239 [TBL] [Abstract][Full Text] [Related]
10. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma. Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436 [TBL] [Abstract][Full Text] [Related]
11. Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants. Ylikorkala O; Pekonen F; Viinikka L J Clin Endocrinol Metab; 1986 Dec; 63(6):1307-12. PubMed ID: 3536979 [TBL] [Abstract][Full Text] [Related]
12. Increased urinary 6-keto-PGF1 alpha excretion during water immersion is blunted by metoclopramide in normal man. Minuz P; Coruzzi P; Paluani F; Ravanetti C; Lechi C; Delva P; Lechi A; Novarini A J Endocrinol Invest; 1989 Oct; 12(9):597-600. PubMed ID: 2511238 [TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of 2,3-dinor-6-keto-PGF1 alpha and 11-dehydro-TXB2 by the gravid spontaneously hypertensive rat. Schaefer WR; Seufert RJ; Casper FW; Zahradnik HP Prostaglandins; 1996 Jul; 52(1):1-11. PubMed ID: 8875634 [TBL] [Abstract][Full Text] [Related]
14. Development of a GC-MS method for quantitation of 2,3-dinor-TxB2 and determinations of the daily urinary excretion rates in healthy humans. Vesterqvist O; Gréen K; Lincoln FH; Sebek OK Thromb Res; 1984 Jan; 33(1):39-49. PubMed ID: 6695361 [TBL] [Abstract][Full Text] [Related]
15. Selective solid-phase extraction of urinary 2,3-dinor-6-ketoprostaglandin F1 alpha for determination with radioimmunoassay. Riutta A; Nurmi E; Weber C; Hansson G; Vapaatalo H; Mucha I Anal Biochem; 1994 Aug; 220(2):351-9. PubMed ID: 7978278 [TBL] [Abstract][Full Text] [Related]
16. Determination of 2,3-dinor-6-ketoprostaglandin F1 alpha in urine samples by liquid chromatography and radioimmunoassay. Casas J; Rosello J; Gelpí E; Guarner F; Guarner C; Quiroga J; Colina I; Prieto J J Chromatogr; 1986 Dec; 383(2):317-24. PubMed ID: 3558562 [TBL] [Abstract][Full Text] [Related]
17. Excretion of primary prostanoids and their metabolites during acute volume expansion. Seyberth HW; Tulassay T; Kühl PG; Soeding K; Rascher W; Schweer H Prostaglandins; 1988 Feb; 35(2):221-32. PubMed ID: 3163156 [TBL] [Abstract][Full Text] [Related]
18. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins. Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690 [TBL] [Abstract][Full Text] [Related]
19. Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man. Rosenkranz B; Fischer C; Weimer KE; Frölich JC J Biol Chem; 1980 Nov; 255(21):10194-8. PubMed ID: 7000774 [TBL] [Abstract][Full Text] [Related]
20. Prostacyclin and thromboxane in pregnant and nonpregnant women in response to exercise. Rauramo I; Ilmonen S; Viinikka L; Ylikorkala O Obstet Gynecol; 1995 Jun; 85(6):1027-30. PubMed ID: 7770249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]